Clinical Trial Update: Gabapentin for Bipolar & Cannabis Use Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating gabapentin for bipolar disorder and cannabis use disorders has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Bipolar Ii Disorder
• Cannabis Use Disorder
• Substance Use Disorders

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Bipolar I Disorder, Bipolar II Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-11-13